Recent research focusing on Tirzepatide at a dosage of 40mg is shedding new light on its potential effects. Preliminary findings suggest that this higher dosage may boost the drug's ability to manage blood sugar, potentially offering greater outcomes for individuals with insulin resistance. Further study is underway to fully explore the long-term s